Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 20Carcinoma, Renal Cell 12Colorectal Neoplasms 10Kidney Neoplasms 8Ovarian Neoplasms 6Neoplasms 5Carcinoma, Transitional Cell 5Urethral Neoplasms 4Stomach Neoplasms 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Multiple Myeloma 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Urothelial Carcinoma of the Bladder 1

Interventions

pembrolizumab 3tislelizumab 1spartalizumab 1milademetan 1enzalutamide 1devimistat 1dehydroftorafur 1Tablets 1Specimen Handling 1Solutions 1Rogaratinib 1Pemetrexed 1Midazolam 1Magnetic Resonance Spectroscopy 1Letrozole 1IFL protocol 1Hydroxychloroquine 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Cetuximab 1Carboplatin 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Fluorouracil × Genitourinary × Clear all
NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Northwestern University

Phase 2 Recruiting
94 enrolled
GastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡